Page last updated: 2024-12-08

1-methyl-4-piperidyl acetate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

1-Methyl-4-piperidyl acetate, also known as **MPPA**, is a chemical compound that is a **synthetic analogue of acetylcholine**. It's important for research because of its **potential therapeutic applications** and its role in **understanding cholinergic systems**.

Here's a breakdown of its key aspects:

**Structure and Properties:**

* MPPA is an **ester derivative of 4-hydroxypiperidine**, a natural compound found in the brain.
* It's a white crystalline solid with a melting point of 105-107°C.
* It's **soluble in water** and various organic solvents.

**Mechanism of Action:**

* MPPA acts as a **cholinergic agonist**, meaning it mimics the effects of acetylcholine in the brain.
* It binds to and activates **muscarinic acetylcholine receptors**, particularly the M1 subtype.
* This activation can lead to various effects, including:
* **Increased cognitive function:** MPPA has shown promise in animal studies for improving memory and learning.
* **Anti-inflammatory effects:** It can reduce inflammation by modulating immune cells.
* **Neuroprotection:** It may offer protection against neuronal damage in conditions like Alzheimer's disease.

**Research Significance:**

* **Alzheimer's disease:** MPPA is being explored as a potential treatment for Alzheimer's disease, which is characterized by cholinergic dysfunction.
* **Cognitive enhancement:** It's also being investigated for its potential to enhance cognitive function in healthy individuals.
* **Understanding cholinergic systems:** MPPA is used as a tool to study the roles of muscarinic receptors and acetylcholine signaling in various physiological processes.

**Safety and Limitations:**

* While MPPA shows promise, it's still in the early stages of research.
* More studies are needed to evaluate its long-term safety and efficacy in humans.
* It's important to note that MPPA can have **side effects**, including nausea, vomiting, and dizziness.

**In summary, 1-Methyl-4-piperidyl acetate is a promising compound for research due to its potential therapeutic applications in areas such as Alzheimer's disease and cognitive enhancement. Its role in understanding cholinergic systems makes it a valuable tool for neuroscientists.**

**Please note:** This information is for educational purposes only and should not be taken as medical advice. Always consult a healthcare professional for any health concerns.

1-methyl-4-piperidyl acetate: radiotracer for acetylcholinesterase; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID151427
CHEMBL ID177847
SCHEMBL ID6954112
MeSH IDM0268728

Synonyms (23)

Synonym
1-methyl-4-piperidinol acetate (ester)
1-methyl-4-piperidyl acetate
brn 1423837
4-piperidinol, 1-methyl-, acetate (ester)
(1-methylpiperidin-4-yl) acetate
FT-0651683
CHEMBL177847
(1-methyl-4-piperidyl) acetate
A835498
6659-34-3
sjo800uk0l ,
n-methyl-4-piperidyl acetate
5-21-01-00054 (beilstein handbook reference)
unii-sjo800uk0l
AKOS015918792
1196157-88-6
1-methyl-4-piperidinyl acetate
methyl-4-piperidyl acetate
SCHEMBL6954112
mp4a
DTXSID90216754
4-piperidinol, 1-methyl-, 4-acetate
acetic acid (1-methyl-4-piperidinyl) ester
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (4)

Assay IDTitleYearJournalArticle
AID19235Partition coefficient (logD) (octanol/phosphate buffer)2004Bioorganic & medicinal chemistry letters, Apr-19, Volume: 14, Issue:8
N-[18F]fluoroethylpiperidin-4-ylmethyl butyrate: a novel radiotracer for quantifying brain butyrylcholinesterase activity by positron emission tomography.
AID44419Specificity to butyrylcholinesterase; ND=No data2004Bioorganic & medicinal chemistry letters, Apr-19, Volume: 14, Issue:8
N-[18F]fluoroethylpiperidin-4-ylmethyl butyrate: a novel radiotracer for quantifying brain butyrylcholinesterase activity by positron emission tomography.
AID19233Partition coefficient (logD)2004Bioorganic & medicinal chemistry letters, Apr-19, Volume: 14, Issue:8
N-[18F]fluoroethylpiperidin-4-ylmethyl butyrate: a novel radiotracer for quantifying brain butyrylcholinesterase activity by positron emission tomography.
AID90920The estimated hydrolysis rate in the human cerebral cortex2004Bioorganic & medicinal chemistry letters, Apr-19, Volume: 14, Issue:8
N-[18F]fluoroethylpiperidin-4-ylmethyl butyrate: a novel radiotracer for quantifying brain butyrylcholinesterase activity by positron emission tomography.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (24)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's3 (12.50)18.2507
2000's11 (45.83)29.6817
2010's10 (41.67)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.33

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.33 (24.57)
Research Supply Index3.40 (2.92)
Research Growth Index4.73 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.33)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials5 (20.83%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other19 (79.17%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]